The U.S. Food and Drug Administration granted four new emergency use authorizations for COVID-19 polymerase chain reaction (PCR) testing products, including a test cleared for use with saliva samples collected at home from P23 Labs of Little Rock, AR.
Authorizations were granted to the following products on May 21:
- P23 Labs' TaqPath SARS-CoV-2 Assay
- BioCore's 2019-nCoV Real Time PCR kit
- SolGent's DiaPlexQ Novel Coronavirus (2019-nCoV) detection kit
- Seasun Biomaterials' AQ-TOP COVID-19 rapid detection kit